12476-1-AP
antibody from Proteintech Group
Targeting: SEPTIN4
ARTS, C17orf47, CE5B3, FLJ40121, H5, hCDCREL-2, hucep-7, MART, PNUTL2, SEPT4
Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 12476-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#12476-1-AP, RRID:AB_2187151
- Product name
- Septin 4 antibody
- Antibody type
- Polyclonal
- Description
- KD/KO validated Septin 4 antibody (Cat. #12476-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IP, WB, ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma.
A novel mutation in CFAP47 causes male infertility due to multiple morphological abnormalities of the sperm flagella.
Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A.
Septin4 Prevents PDGF-BB-induced HAVSMC Phenotypic Transformation, Proliferation and Migration by Promoting SIRT1-STAT3 Deacetylation and Dephosphorylation.
Septin4 as a novel binding partner of PARP1 contributes to oxidative stress induced human umbilical vein endothelial cells injure.
Blua F, Monge C, Gastaldi S, Clemente N, Pizzimenti S, Lazzarato L, Senetta R, Vittorio S, Gigliotti CL, Boggio E, Dianzani U, Vistoli G, Altomare AA, Aldini G, Dianzani C, Marini E, Bertinaria M
Bioorganic chemistry 2024 Mar;144:107164
Bioorganic chemistry 2024 Mar;144:107164
A novel mutation in CFAP47 causes male infertility due to multiple morphological abnormalities of the sperm flagella.
Liu M, Dai S, Zhang J, Yang Y, Shen Y, Liu H, Yang Y, Jiang C, Tian E
Frontiers in endocrinology 2023;14:1155639
Frontiers in endocrinology 2023;14:1155639
Atorvastatin rescues vascular endothelial injury in hypertension by WWP2-mediated ubiquitination and degradation of ATP5A.
Yin Z, You S, Zhang S, Zhang L, Wu B, Huang X, Lu S, Cao L, Zhang Y, Li D, Zhang X, Liu J, Sun Y, Zhang N
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Oct;166:115228
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 Oct;166:115228
Septin4 Prevents PDGF-BB-induced HAVSMC Phenotypic Transformation, Proliferation and Migration by Promoting SIRT1-STAT3 Deacetylation and Dephosphorylation.
Zhang N, Zhang Y, You S, Tian Y, Lu S, Cao L, Sun Y
International journal of biological sciences 2020;16(4):708-718
International journal of biological sciences 2020;16(4):708-718
Septin4 as a novel binding partner of PARP1 contributes to oxidative stress induced human umbilical vein endothelial cells injure.
Zhang N, Zhang Y, Zhao S, Sun Y
Biochemical and biophysical research communications 2018 Feb 5;496(2):621-627
Biochemical and biophysical research communications 2018 Feb 5;496(2):621-627
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The SEPT4 antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human SEPT4. This antibody recognizes human antigen. The SEPT4 antibody has been validated for the following applications: ELISA, WB analysis.